✦ LIBER ✦
Addition of topical pimecrolimus to once-daily mid-potent steroid confers no short-term therapeutic benefit in the treatment of severe atopic dermatitis; a randomized controlled trial
✍ Scribed by J.M. Spergel; M. Boguniewicz; A.S. Paller; A.A. Hebert; P.R. Gallagher; C. McCormick; A. Parneix-Spake; T. Hultsch
- Book ID
- 108669527
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 123 KB
- Volume
- 157
- Category
- Article
- ISSN
- 0007-0963
No coin nor oath required. For personal study only.